PharmaShots | Incisive News in 3 Shots

Subscribe Now

Breast

Celltrion's Herzuma (biosimilar- trastuzumab) Overtook the Original Treatments for Cancer

Celltrion's Herzuma (biosimilar- trastuzumab) Overtook the Original Treatments for Cancer

August 11, 2021

Daiichi Sankyo and AZ's Trastuzumab Deruxtecan Receives CHMP's Recommendation for Approval to Treat HER2 Positive Metastatic Breast Cancer

Daiichi Sankyo and AZ's Trastuzumab Deruxtecan Receives CHMP's Recommendation for Approval to Treat HER2 Positive Metastatic Breas...

December 14, 2020

Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer

Roche Launches Ventana HER2 Dual ISH CDx for the Identification of Breast and Gastric Cancer

April 23, 2019

Samsung Bioepis' Biosimilar Transtuzumab Ontruzant (transtuzumab-dttb)- Receives US FDA Approval for Oncology Indications

Samsung Bioepis' Biosimilar Transtuzumab Ontruzant (transtuzumab-dttb)- Receives US FDA Approval for Oncology Indications

January 21, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us